Andere talen Pila Pharma AB

Aandelen

PILA

SE0015988274

Beurs gesloten - Nasdaq Stockholm Andere beurzen 18:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,3 ^SEK	+11,69%		+0,23%	+168,75%

19/04	Pila Pharma AB (Publ) kondigt bestuurs- en managementbenoemingen aan	CI
19/04	Pila Pharma AB (publ) kondigt wijzigingen in CEO aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Pila Pharma Appoints New CEO, Chief Scientific Officer	19/04
Pila Pharma AB Announces Board and Management Appointments	19/04
Pila Pharma AB Announces CEO Changes	19/04
Pila Pharma Nominates CEO as Chair	21/03
Pila Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Pila Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Pila Pharma Enters Research Collaboration to Study Heart Disease Treatment in Mice	27/11
Pila Pharma AB Enters Research Collaboration with the Research Group of Professor Dick Wagsater, Uppsala University, Sweden	26/11
Pila Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	25-10-23
Pila Pharma AB announced a financing transaction	24-08-23
Pila Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-23
Pila Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023	26-04-23
Pila Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	28-02-23
Pila Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	26-10-22
BioStock: Pila Pharma broadens XEN-D0501 with new indication	31-08-22
BioStock: Pila Pharma's CEO comments on the Q2 report	30-08-22
Pila Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	26-08-22
BioStock: Pila Pharma initiates toxicological studies	05-07-22
Pila Pharma AB Announces the Preclinical Toxicological Three-Month Studies of the Active Substance Xen-D0501 Has Begun	30-06-22
BioStock: Deep dive into Pila Pharma's clinical concept	25-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Pila Pharma AB

Aandelen

PILA

SE0015988274

Andere talen

Filters